November 6, 2018
Democrats have tried to make Tuesday’s elections about health care.
As with most issues, they equate government spending with success — liberals claim they care more than conservatives because they spend more of other people’s hard-earned money.
Full disclosure: My husband, Russ Vought, is deputy director of the Office of Management and Budget. But speaking strictly as the mother of a child with a life-threatening genetic disease, I know that other policy changes can make a critical impact on the lives of sick patients without government spending.
And so does the Trump administration, which has taken several vital steps to reorient the federal bureaucracy toward the chronically ill and individuals with pre-existing conditions.
First, the administration has made expanded access to prescription drugs a top priority. In the fiscal year that ended on Sept. 30, the Food and Drug Administration OK’d 971 generic drugs — a record, breaking the old mark of 937 approvals set just last year. Compare that to the 651 green-lighted in 2016 and the 492 the year before under President Barack Obama.
This article was posted: Tuesday, November 6, 2018 at 6:37 am